Tracking Pain and Opioid Use in Young Sarcoma Survivors
Studies how easy it is to track pain and opioid use in sarcoma survivors.
Plain-language title generated from the registry record
Registry title: Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
Key facts
- Where
- Buffalo, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 70 years old?
Source: NCT07402577, who can take part
Where in United States
- Roswell Park Comprehensive Cancer CenterBuffalo, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Roswell Park Cancer Institute
- Trial code
- NCT07402577
- Record updated
- 15 April 2026
- Original description
This study generates information on the feasibility and acceptability of a 3-month ecological momentary assessment (EMA) protocol to assess chronic pain and opioid use in adolescent and young adult (AYA) sarcoma survivors.Read full original descriptionShow less
Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
This study generates information on the feasibility and acceptability of a 3-month ecological momentary assessment (EMA) protocol to assess chronic pain and opioid use in adolescent and young adult (AYA) sarcoma survivors.
Inclusion: All genders between the ages of 12-24 (inclusive) at sarcoma diagnosis; Any age < 70 at the time of study enrollment; No evidence of disease and/or enrolled in survivorship care; Clinically meaningful pain related to disease or its treatments at baseline (defined as 3 or greater on a 0-10 Numerical Rating Scale); Willing to attend the baseline appointment in person; Access to internet-capable smartphone; Access to internet on an occasional basis; Willing and able to complete Ecological Momentary Assessments (EMAs) on internet-capable smartphone for a 3-month period after enrollment; Ability to understand and provide informed consent/assent.
Exclusion: * Currently receiving active cancer-directed therapy; Unable to read or fluently speak English; Determined by clinical staff to have preexisting or cancer-associated cognitive impairment that could interfere with study participation; Acutely suicidal (e.g. intent or plan) or, with unstable medical or psychiatric condition verified by licensed study staff; Characteristics related to inability to complete the study protocol.